Topic: European Commission

EU opens first probe into abusive drug patent filings

The European Commission is investigating whether Teva Pharmaceuticals unlawfully delayed the entry of generic drugs to treat multiple sclerosis through patent litigation and a disparaging communications campaign that discredited its competitors.

04 March 2021

EU will soon legislate against anticompetitive foreign subsidies, Vestager says

The European Commission hopes to put out draft legislation aimed at tackling distortive foreign subsidies in the next three or four months, the EU’s competition commissioner has said.

04 March 2021

DMA is not the end of antitrust enforcement, Guersent says

The director-general of the European Commission’s competition authority has stressed that the agency will not be giving up on traditional antitrust enforcement in the digital economy following the introduction of the Digital Markets Act.

02 March 2021

ECJ rules Slovak Telecom fines can still stand

Separate abuse of dominance fines imposed by Slovakia's competition enforcer and the European Commission on Slovak Telekom did not breach EU law, because they related to conduct in different markets, the European Court of Justice has ruled.

26 February 2021

VodafoneZiggo loses challenge to EU regulatory recommendations

The European Commission’s recommendations to national regulatory authorities cannot be challenged before the EU courts as they do not constitute a “legal decision”, the European Court of Justice has ruled.

25 February 2021

Vestager questioned on essential facilities omission from DMA

Margrethe Vestager has defended the omission of any reference to essential facilities in the European Commission’s proposed Digital Markets Act, arguing that the agency has found a middle ground between that doctrine and competition law enforcement.

23 February 2021

EU clears Siemens Healthineers/Varian with interoperability remedies

The European Commission has cleared Siemens Healthineers $16.4 billion acquisition of Varian Medical Systems, on the condition that the companies make their respective medical imaging and radiotherapy devices interoperable with rival products.

22 February 2021

EU slaps rare new measures on Novelis/Aleris

The European Commission has imposed new final commitments on Novelis relating to its €2.3 billion acquisition of rival Aleris in 2019, after the company invalidated the enforcer’s initial clearance decision by missing divestiture deadlines.

19 February 2021

Epic heads to EU in fight against Apple

Epic Games has continued its global crusade against Apple by filing an antitrust complaint with the European Commission.

17 February 2021

EU clears crop deal with remedies

The European Commission has cleared a deal between two suppliers of crop protection products following a Phase I probe, on the condition that the companies first divest certain supply agreements.

12 February 2021

Get unlimited access to all Global Competition Review content